🇺🇸 FDA
Patent

US 7678828

Methods for the formulation and manufacture of artesunic acid for injection

granted A61KA61K31/357A61K9/0019

Quick answer

US patent 7678828 (Methods for the formulation and manufacture of artesunic acid for injection) held by The United States of America as represented by the Secretary of the Army expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/357, A61K9/0019, A61P, A61P33/06